[Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria; D066298:In Vitro Techniques; D009921:Metaproterenol / Q000037:antagonists & inhibitors; D009570:Nitriles / Q000494:pharmacology*; D011427:Propiophenones / Q000494:pharmacology*; D011955:Receptors, Drug; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D011427:Propiophenones; D011955:Receptors, Drug; D013565:Sympatholytics; D014665:Vasodilator Agents; D009921:Metaproterenol; D014700:Verapamil
Untersuchungen über den Wirkungsmechanismus von INPEA, Iproveratril und Oxyfedrin.